Latest news

Research3

Establishment and inaugural meeting of the Clinical and Scientific Advisory Board

Synapse Electroceutical Limited are delighted to announce the establishment of a Clinical and Scientific Advisory Board comprised of eminent experts in the fields of Wound Healing research, science, clinical practice, pain management and health economics.

Read this article

Synapse CEO announcement

Synapse Electroceutical today announced that the Board of Directors has appointed Andy Boyes as Interim Chief Executive Officer. John Gildersleeve will assume the role of Business Development Director and will continue to serve as an executive director on the Board.

Read this article
Become a Distributor

Andy Boyes appointed as Non-Executive Director to Synapse Electroceutical Limited

Synapse Electroceutical Limited is delighted to announce the appointment of Andy Boyes to the Board. Andy has enjoyed a successful, 32 year career at Smith & Nephew, the FTSE 100 medical technology business engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors with sales in excess of £4 billion. Andy is passionate
about the wound care sector and helping improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has focussed on providing Board level support and strategic direction in the sector.

Read this article

Other articles

Information for Clinicians

Accel-Heal product shot